Rheumatoid arthritis trials in Australia

In Australia 17 Also abroad 351

17 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Study of AZD0120 in Autoimmune Diseases
Where
Clayton, Darlinghurst, Waratah
Age
18 years to 75 years
People
27 worldwide
Run by
AstraZeneca
See details and how to joinNCT07295847
Phase 1Taking people
A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body
Where
Brisbane
Age
18 years to 75 years
People
63
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT07649265
Phase 1Taking people
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Where
Southport
Age
18 years to 75 years
People
21 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07363590 · EU 2025-523412-36-00
Phase 1Taking people
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Where
Birtinya, Clayton
Age
18 years to 65 years
People
48 worldwide
Run by
AstraZeneca
See details and how to joinNCT07201558 · EU 2025-522273-10-00
Phase 1Taking people
A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases
Where
Melbourne
Age
18 years to 75 years
People
62 worldwide
Run by
Sanofi
See details and how to joinNCT06647069
Phase 1Taking people
A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases
Where
Melbourne
Age
18 years to 65 years
People
105
Run by
Candid Therapeutics
See details and how to joinNCT07712939
Phase 1Taking people
A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Where
Brisbane, Melbourne
Age
18 years to 55 years
People
68 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07276958 · EU 2026-527207-25-00
Phase 2Taking people
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Where
Perth
Age
18 years to 75 years
People
220 worldwide
Run by
Amgen
See details and how to joinNCT06570798
No phaseTaking people
The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis
Where
Fitzroy, Ivanhoe
Age
18 years to 75 years
People
5
Run by
The Bionics Institute of Australia
See details and how to joinNCT07017686
Phase 1Taking people
Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis
Where
Melbourne
Age
18 years to 75 years
People
176 worldwide
Run by
Lifordi Immunotherapeutics, Inc.
See details and how to joinNCT07207954
Phase 1Taking people
A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA)
Where
Bayswater
Age
18 years to 75 years
People
27 worldwide
Run by
Kali Therapeutics, Inc.
See details and how to joinNCT07564154
Phase 1Taking people
A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)
Where
Bayswater, Herston, Nedlands
Age
18 years to 65 years
People
64
Run by
Capstan Therapeutics
See details and how to joinNCT06917742
Phase 1Taking people
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Where
Brisbane, Camperdown, Clayton
Age
18 years and over
People
125 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00
No phaseTaking people
Clinical Outcomes Study of the Nexel Total Elbow
Where
Sydney
Age
18 years and over
People
134 worldwide
Run by
Zimmer Biomet
See details and how to joinNCT02469662
Phase 1Taking people
Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Where
Birtinya, Charlestown
Age
18 years to 75 years
People
24
Run by
Seismic Therapeutic AU Pty Ltd
See details and how to joinNCT07455578
Phase 1Taking people
A First-in-human Study of KT501 Administered Subcutaneously to Patients With Rheumatoid Arthritis (RA).
Where
Bayswater
Age
18 years to 75 years
People
24
Run by
Kali Therapeutics, Inc.
See details and how to joinNCT07234773
No phaseTaking people
A Prospective, Pre-market, Multi-center Study of Insignia Hip Stem in THA to Determine Implant Survivorship and PROMS.
Where
Subiaco
Age
18 years and over
People
313
Run by
Stryker Australia Pty Ltd.
See details and how to joinNCT06108934